advent
pcr
transform
util
viru
diagnost
laboratori
comparison
tradit
gel
base
pcr
assay
real
time
pcr
offer
increas
sensit
specif
rapid
format
past
year
introduc
number
qualit
quantit
real
time
pcr
assay
routin
test
servic
period
gain
substanti
experi
relat
develop
implement
realtim
assay
furthermor
develop
strategi
allow
us
increas
sampl
throughput
maintain
even
reduc
turn
around
time
issu
result
experi
bad
discuss
detail
aim
inform
laboratori
begin
investig
potenti
technolog
advent
polymeras
chain
reaction
pcr
transform
util
viru
diagnost
laboratori
comparison
tradit
method
pcr
offer
highli
sensit
specif
result
within
h
routin
use
test
diagnost
laboratori
led
mani
benefit
includ
improv
patient
manag
increas
ascertain
previous
underdiagnos
undetect
virus
advent
real
time
pcr
technolog
improv
upon
alreadi
signific
benefit
arya
et
al
aslanzadeh
bustin
nolan
mackay
tan
et
al
comparison
tradit
gelbas
pcr
assay
real
time
pcr
offer
increas
sensit
specif
rapid
format
turn
around
time
sampl
receipt
result
h
unlik
tradit
system
reli
upon
endpoint
analysi
real
time
pcr
assay
visualis
reaction
take
place
allow
quantif
reaction
analysi
eg
pcr
effici
sinc
real
time
pcr
reaction
perform
close
system
gel
analysi
need
risk
contamin
substanti
reduc
also
reduc
requir
stringent
laboratori
structur
increas
number
chemistri
platform
avail
real
time
pcr
reduc
overal
cost
significantli
make
increasingli
attract
techniqu
past
year
introduc
number
qualit
quantit
real
time
pcr
assay
routin
test
servic
includ
assay
detect
influenza
b
c
human
metapneumoviru
respiratori
syncyti
virus
rsv
b
rhinoviru
parainfluenza
virus
coronavirus
chlamydia
pneumonia
mycoplasma
pneumonia
pneumocysti
jiroveci
varicella
zoster
viru
vzv
herp
simplex
viru
hsv
cytomegaloviru
cmv
epstien
barr
viru
ebv
noroviru
adenoviru
rotaviru
astroviru
sapoviru
erythroviru
mump
chlamydia
trachomati
mycoplasma
genitalium
nesseria
gonnorhoea
enteroviru
year
carri
pcr
test
period
gain
substanti
experi
relat
develop
implement
real
time
assay
furthermor
develop
strategi
allow
us
increas
sampl
throughput
maintain
even
reduc
turn
around
time
issu
result
experi
bad
discuss
detail
aim
inform
laboratori
begin
investig
potenti
technolog
numer
chemistri
avail
carri
real
time
pcr
includ
dual
label
probe
often
known
taqman
tm
probe
minor
groov
bind
mgb
probe
molecular
beacon
fluoresc
energi
transfer
fret
probe
intercal
dye
sybr
green
recent
develop
fluoresc
label
primer
sunris
tm
lux
tm
scorpion
primer
tm
advantag
disadvantag
chemistri
discuss
arya
et
al
aslanzadeh
bustin
nolan
mackay
tan
et
al
tabl
publish
real
time
probe
base
pcr
assay
viral
diagnosi
utilis
either
molecular
beacon
dual
label
probe
although
recent
public
tend
favour
use
dual
label
probe
current
real
time
pcr
test
dual
label
probe
assay
howev
experi
method
note
sever
import
differ
two
system
consid
develop
implement
diagnost
virolog
test
molecular
beacon
specif
tyagi
kramer
specif
direct
result
structur
free
solut
molecular
beacon
adopt
hairpinloop
conform
report
fluoresc
quench
proxim
quencher
molecul
fig
stabl
state
molecular
beacon
bind
target
sequenc
becom
linear
fluoresc
highli
complementari
nucleotid
differ
beacon
target
sequenc
greatli
reduc
target
bind
effici
probe
result
molecular
beacon
increas
propens
fals
neg
result
encount
problem
implement
previous
publish
molecular
beacon
base
test
detect
parainfluenza
virus
initi
assess
detect
culturedirect
immunofloresc
parainfluenza
posit
sampl
detect
howev
parainfluenza
posit
sampl
detect
dif
cultur
neg
test
assay
assess
whether
primer
amplifi
parainfluenza
viral
rna
sybr
green
ad
pcr
reaction
place
molecular
beacon
format
pcr
product
observ
use
melt
curv
analysi
ident
melt
peak
observ
parainfluenza
sampl
control
fig
run
pcr
product
agaros
gel
observ
band
expect
size
confirm
success
amplif
parainfluenza
rna
primer
base
result
deduc
molecular
beacon
longer
complementari
amplifi
target
sequenc
consequ
follow
analysi
recent
avail
sequenc
databas
new
molecular
beacon
design
detect
parainfluenza
sampl
fig
unlik
molecular
beacon
dual
label
probe
perman
linear
conform
lee
et
al
fig
like
primer
toler
small
number
mismatch
probe
target
still
bind
target
consequ
dual
label
probe
less
like
result
fals
neg
reaction
may
comparison
molecular
beacon
greater
use
viral
diagnosi
occasion
chang
even
conserv
target
sequenc
may
expect
occur
although
note
mismatch
also
lead
fals
neg
reaction
dual
label
probe
howev
either
method
use
target
highli
conserv
region
second
differ
molecular
beacon
dual
label
probe
chemistri
relat
normalis
fig
figur
show
assess
whether
real
time
molecular
beacon
primer
amplifi
parainfluenza
viral
rna
reaction
sybr
green
ad
pcr
reaction
place
molecular
beacon
sampl
neg
molecular
beacon
assay
format
pcr
product
observ
use
melt
curv
analysi
ident
melt
peak
observ
parainfluenza
sampl
control
http
fig
dual
label
probe
also
known
taqman
tm
probe
oligonucleotid
contain
fluoresc
dye
base
quench
dye
locat
base
excit
flouresc
dye
transfer
energi
nearbi
quench
dye
molecul
rather
fluoresc
result
nonfluoresc
probe
dual
label
probe
design
hybrid
intern
region
pcr
product
pcr
polymeras
replic
templat
probe
bound
exonucleas
activ
polymeras
cleav
probe
separ
fluoresc
quench
dye
fret
longer
occur
allow
detect
signal
report
dye
fluoresc
increas
cycl
proport
rate
probe
cleavag
chang
fluoresc
r
n
produc
success
real
time
pcr
found
case
dual
label
probe
produc
greater
fluoresc
chang
molecular
beacon
fig
larger
r
n
allow
easier
interpret
result
low
posit
result
mayb
easili
differenti
variabl
background
dual
label
probe
provid
greater
fluoresc
chang
report
dye
irrevers
releas
quencher
extens
stage
pcr
cycl
consequ
cumul
perman
record
success
amplif
ad
subsequ
pcr
cycl
molecular
beacon
destroy
end
cycl
return
free
solut
denatur
phase
revert
back
hairpinloop
structur
consequ
accumul
free
report
dye
extra
fluoresc
produc
less
cycl
compar
dual
label
probe
sinc
real
time
pcr
rel
new
techniqu
publish
assay
may
avail
viral
pathogen
result
mani
laboratori
may
wish
develop
novel
inhous
real
time
pcr
assay
initi
stage
develop
real
time
pcr
assay
requir
design
tradit
gel
base
pcr
test
first
step
identifi
conserv
region
viral
pathogen
genom
design
assay
literatur
review
often
reveal
gene
conserv
often
gene
encod
nonimmunogen
protein
gene
identifi
blast
search
http
wwwncbinlmnihgovblast
perform
locat
conserv
region
within
gene
real
time
amplicon
short
contain
third
oligonucleotid
ie
probe
ideal
region
design
assay
would
nucleotid
long
region
base
devoid
base
degeneraci
best
find
conserv
region
base
allow
softwar
identifi
number
potenti
assay
sever
softwar
program
avail
design
real
time
assay
often
softwar
provid
instrument
supplier
beacon
design
pre
fig
comparison
r
n
produc
use
dual
label
probe
vs
molecular
beacon
b
tabl
main
factor
consid
develop
dual
label
probe
pcr
assay
factor
consid
develop
dual
label
probe
pcr
assay
identifi
conserv
region
viral
pathogen
genom
identifi
region
within
area
base
length
check
probe
sequenc
contain
c
residu
g
residu
ensur
probe
begin
g
optim
primer
valu
c
optim
probe
c
higher
amplicon
exceed
bp
length
primer
contain
g
c
residu
check
amplicon
secondari
structur
specif
mier
biosoft
use
design
either
molecular
beacon
assay
dual
label
probe
base
assay
addit
function
blast
secondari
structur
search
primer
express
appli
biosystem
anoth
use
tool
design
taqman
base
assay
softwar
current
avail
design
assay
base
appli
biosystem
abi
mgb
probe
softwar
suggest
primer
probe
set
import
ensur
meet
criteria
tabl
assum
primer
probe
meet
criteria
advis
check
amplicon
secondari
structur
specif
secondari
structur
predict
softwar
avail
internet
exampl
michael
zuker
mfold
server
http
particularli
use
highli
structur
amplicon
higher
g
may
reduc
effici
revers
transcript
primer
anneal
fig
may
reduc
overal
sensit
assay
final
stage
design
process
check
amplicon
specif
use
blast
algorithm
http
wwwncbinlmnihgovblast
assay
specif
sequenceorgan
interest
detect
sequenc
nonspecif
match
may
pick
closer
analysi
primer
probe
bind
site
often
confirm
sequenc
amplifi
detect
due
multipl
base
chang
perform
gel
base
pcr
essenti
fulli
optimis
primer
concentr
achiev
best
sensit
assay
best
endpoint
signal
bright
band
gunson
et
al
real
time
pcr
signal
detect
earli
amplif
process
therefor
endpoint
variat
seen
gelbas
assay
affect
result
also
care
design
assay
reduc
primerdim
format
fig
structur
within
pcr
amplicon
may
affect
sensit
assay
respiratori
synciti
viru
rsv
detect
limit
copiesreact
rsvb
structur
detect
limit
copi
per
reaction
increas
effici
specif
amplif
reaction
consequ
mani
manufactur
real
time
pcr
equip
oligonucleotid
primer
probe
longer
recommend
optimis
primer
probe
concentr
real
time
taqman
assay
despit
still
perform
initi
optimis
primer
probe
concentr
ensur
run
real
time
pcr
assay
sensit
effici
although
major
assay
optim
concentr
nm
forward
revers
probe
observ
sever
occas
optim
primer
probe
concentr
differ
valu
recommend
method
primer
probe
optimis
avail
onlin
wwwclinicalvirologyorg
howev
method
also
avail
optimis
real
time
pcr
requir
posit
control
materi
posit
control
avail
exampl
viru
cultur
highli
pathogen
viru
influenza
sar
coronaviru
dna
rna
oligonucleotid
target
may
order
also
use
altern
plasmid
standard
quantit
assay
note
oligonucleotid
control
must
order
separ
supplier
prevent
contamin
primerprob
set
dilut
separ
laboratori
prior
use
may
contain
target
copi
per
ml
therefor
consider
sourc
potenti
contamin
observ
contamin
erythroviru
primer
purchas
sever
month
full
length
oligonucleotid
control
order
supplier
fig
assay
optimis
essenti
check
sensit
specif
new
pcr
assay
use
select
sampl
panel
much
debat
accept
valid
process
minim
includ
clinic
sampl
known
posit
current
standard
assay
consist
sampl
type
commonli
submit
examin
viru
question
clinic
sampl
test
neg
previou
method
also
examin
determin
new
assay
sensit
current
test
sampl
known
posit
agent
test
confirm
assay
fig
contamin
primer
probe
assay
target
produc
facil
label
reaction
compon
supplier
salt
free
neg
control
mean
c
valu
label
reaction
compon
supplier
salt
free
posit
control
mean
c
valu
label
reaction
compon
supplier
hplc
neg
control
mean
c
valu
label
reaction
compon
supplier
hplc
posit
control
mean
c
valu
label
reaction
compon
supplier
b
neg
control
mean
c
valu
label
reaction
compon
supplier
b
posit
control
mean
c
valu
full
length
dna
oligonucleotid
repres
amplicon
real
time
pcr
assay
synthesis
supplier
later
investig
assay
contamin
follow
reagent
chang
primer
probe
purchas
supplier
salt
free
hplc
purifi
altern
supplier
b
reagent
purchas
supplier
b
clean
whilst
supplier
contamin
previous
synthesis
posit
control
even
hplc
purif
specif
serial
dilut
seri
known
posit
sampl
may
also
prepar
test
parallel
new
previou
assay
system
determin
assay
sensit
ideal
dilut
panel
repres
subgroup
target
viru
ensur
test
sensit
type
new
test
must
least
sensit
assay
current
use
ideal
abl
detect
wider
rang
viru
subtypesvari
addit
method
valid
new
assay
test
assay
use
sampl
extern
qualiti
assur
program
panel
may
obtain
variou
sourc
includ
nation
extern
qualiti
assess
servic
neqa
qualiti
control
molecular
diagnost
qcmd
expect
result
may
compar
obtain
old
new
assay
parallel
use
panel
also
allow
comparison
assay
current
use
differ
laboratori
implement
newli
design
previous
publish
assay
number
chang
made
order
reduc
turn
around
time
assay
increas
laboratori
throughput
multiplex
real
time
pcr
assay
allow
detect
multipl
pathogen
within
singl
tube
utilis
assay
reduc
overal
test
cost
turn
around
time
enabl
high
throughput
number
multiplex
real
time
pcr
assay
describ
literatur
draganov
kulvachev
gunson
et
al
hindiyeh
et
al
richard
et
al
templeton
et
al
recent
describ
triplex
assay
design
detect
respiratori
viral
pathogen
design
multiplex
real
time
pcr
complic
process
often
requir
great
deal
trial
error
outlin
gener
criteria
may
prove
use
design
assay
order
design
appropri
primer
probe
user
follow
develop
protocol
outlin
howev
care
taken
ensur
primer
probe
interact
may
reduc
sensit
effici
pcr
reaction
primer
design
softwar
allow
primerprob
interact
examin
order
optimis
multiplex
assay
separ
pcr
optimis
separ
assess
ad
togeth
see
section
detail
experi
includ
assess
sensit
multiplex
assay
simultan
detect
mix
infect
real
spike
low
copi
target
high
copi
background
ideal
loss
sensit
observ
addit
primer
ad
howev
multiplex
assay
less
sensit
alter
ratio
primersprob
concentr
may
prove
use
altern
chang
concentr
pcr
reagent
enzym
mg
dntp
etc
may
also
benefici
manufactur
produc
real
time
reaction
mix
specif
design
use
multiplex
assay
provid
guidelin
optim
primer
probe
concentr
use
howev
factor
fail
improv
sensit
multiplex
assay
primer
probe
may
redesign
number
target
detect
one
assay
limit
number
detect
channel
avail
real
time
platform
number
fluorescentlabel
dye
avail
newer
machin
tend
five
channel
although
mani
fluoresc
dye
avail
mani
excitationemiss
spectra
overlap
thu
certain
combin
use
present
use
fam
vic
detector
optim
filter
set
utilis
abi
pleas
note
may
differ
use
platform
syndrom
base
test
polici
ideal
rapid
high
throughput
test
laboratori
offer
number
menu
negat
need
clinic
code
allow
sampl
test
immedi
upon
receipt
tabl
exampl
csf
sampl
patient
neurolog
ill
enceph
mening
test
enteroviru
hsv
vzv
ebv
cmv
regardless
patient
clinic
detail
similar
test
protocol
place
urethr
gastroenter
respiratori
ill
eye
infect
howev
although
polici
aid
high
throughput
reduc
turn
around
time
sampl
receipt
result
readi
note
may
expens
occasion
produc
result
difficult
interpret
eg
herp
virus
respiratori
sampl
see
autom
extract
liquid
handl
process
led
signific
improv
turn
around
time
allow
high
throughput
reduc
risk
user
error
mani
manufactur
suppli
autom
equip
extract
nucleic
acid
diagnost
sampl
tabl
manufactur
provid
open
platform
use
supplier
kit
reagent
other
provid
complet
extract
solut
although
univers
extract
kit
dna
rna
pathogen
specimen
type
avail
also
note
differ
kit
use
particular
sampl
type
pathogen
eg
rna
dna
may
sensit
particular
applic
although
autom
extract
mani
advantag
laboratori
also
consid
complement
servic
manual
extract
system
use
test
emerg
sampl
arriv
laboratori
autom
extract
begun
sampl
requir
special
process
suit
autom
eg
tissu
mani
supplier
also
suppli
autom
liquid
handl
equip
facilit
set
larg
number
pcr
reaction
tradit
publish
inhous
develop
real
time
pcr
method
consist
follow
standard
paramet
taq
dna
polymeras
activ
step
usual
c
min
depend
upon
pcr
kit
manufactur
follow
cycl
c
denatur
annealingextens
cycl
c
rna
viru
detect
addit
min
revers
transcript
step
requir
taq
dna
polymeras
activ
overal
reaction
run
time
real
time
pcr
min
repeatedli
shown
use
dilut
seri
number
dna
rna
viral
pathogen
reduc
durat
revers
transcript
step
denatur
annealingextens
step
reduc
reaction
run
time
assay
significantli
without
concurr
loss
sensit
tabl
overal
reaction
run
time
reduc
approxim
min
min
rtpcr
free
pcr
machin
test
allow
test
within
work
day
dual
label
probe
real
time
pcr
assay
design
utilis
pcr
paramet
ie
denatur
step
c
anneal
extent
step
c
theoret
multipl
differ
real
time
pcr
assay
carri
time
sampl
plate
also
shown
dna
rna
reagent
purchas
supplier
therefor
ident
taq
activ
requir
dna
assay
suffer
loss
perform
run
rtpcr
cycl
condit
allow
laboratori
greater
flexibl
provid
rapid
servic
preprepar
frozen
real
time
pcr
reagent
user
friendli
lead
reduc
trt
improv
qualiti
control
qc
compar
prepar
pcr
mix
separ
reagent
assess
two
differ
method
preprepar
real
time
pcr
reagent
frozen
aliquot
pool
primer
probe
frozen
aliquot
contain
real
time
pcr
reagent
system
assess
rel
short
time
period
maximum
week
correspond
maximum
period
time
pool
would
last
run
ideal
would
assess
longer
period
find
pool
primer
probe
approach
best
suit
season
assay
respiratori
pathogen
wherea
latter
approach
suit
assay
perform
regularli
throughout
year
standard
number
sampl
advantag
disadvantag
list
tabl
introduc
pool
primer
probe
major
routin
dna
rna
test
prove
especi
use
high
throughput
assay
respiratori
screen
consist
five
triplex
real
time
rtpcr
assay
multiplex
assay
oper
need
mix
three
tube
contain
prealiquot
reagent
aliquot
mastermix
contain
rox
refer
dye
one
contain
enzym
mix
rt
taq
aliquot
primer
probe
pool
contain
three
set
primer
probe
suffici
water
way
mastermix
prepar
rapidli
reagent
care
qualiti
control
possibl
pipet
calcul
error
time
prepar
reduc
product
larg
number
aliquot
time
suffici
approxim
test
also
facilit
interrun
reproduc
assist
maintain
qualiti
result
mix
unavoid
wast
time
save
reduc
number
fail
run
compens
cost
summer
month
sampl
number
much
reduc
smaller
aliquot
prepar
tabl
show
ct
valu
obtain
coronaviru
triplex
assay
use
pool
primer
probe
store
week
demonstr
stabil
reagent
store
c
use
lot
number
pool
primerprob
coronaviru
assay
excess
week
without
loss
perform
system
pool
control
see
use
abl
provid
effici
reliabl
frozen
pool
primer
probe
mastermix
enzym
use
aliquot
frozen
mastermix
contain
pcr
reagent
except
templat
altern
frozen
primer
probe
aliquot
describ
laboratori
user
need
remov
desir
number
aliquot
plate
frozen
format
defrost
add
templat
test
frozen
aliquot
easier
use
pool
primer
probe
method
facilit
rigor
qualiti
control
reduc
overal
turn
around
time
howev
less
flexibl
primer
probe
aliquot
system
wastag
expens
includ
enzym
furthermor
mistak
make
aliquot
result
loss
primer
probe
expens
mastermix
shown
use
posit
control
rna
dna
mastermix
number
compani
appli
biosystem
invitrogen
qiagen
frozen
least
month
loss
sensit
posit
neg
control
essenti
part
diagnost
pcr
servic
recent
mani
laboratori
utilis
two
dilut
posit
control
viru
test
endpoint
dilut
seri
cultur
viru
test
relev
assay
act
sensit
control
dilut
log
less
dilut
result
robot
extract
run
well
substanti
number
well
requir
posit
control
alon
inclus
neg
extract
control
reduc
possibl
number
extract
avail
sampl
use
numer
control
increas
cost
per
sampl
turnaround
time
servic
pool
control
signific
improv
previou
method
use
separ
pool
contain
respiratori
virus
gastrointestin
pathogen
order
develop
pool
respiratori
gastrointestin
control
viru
cultur
stool
extract
serial
dilut
tabl
ct
posit
control
frozen
primerprob
pool
week
end
point
establish
respiratori
viru
control
high
posit
control
pool
prepar
ad
equal
volum
dilut
log
end
point
cultur
fluid
dilut
high
posit
control
prepar
produc
low
posit
control
includ
two
respiratori
control
robot
extract
free
addit
well
sampl
prepar
larg
volum
control
one
time
allow
better
qc
reproduc
achiev
aliquot
control
store
c
found
stabl
month
far
previous
experienc
lottolot
variat
primer
probe
result
reduct
test
sensit
new
batch
reagent
purchas
run
perform
test
use
new
reagent
concentr
previous
determin
optim
test
old
new
primer
probe
set
parallel
posit
control
pcr
run
c
r
n
valu
observ
compar
newli
prepar
reagent
must
produc
c
valu
fall
within
two
standard
deviat
mean
valu
determin
reagent
previous
use
test
ident
posit
control
new
reagent
releas
routin
use
assay
less
sensit
previou
assay
primer
andor
probe
optimis
take
place
ideal
done
sever
week
next
batch
requir
routin
use
new
probe
primer
may
need
reorder
experi
winter
reoptimis
requir
respiratori
assay
valid
real
time
pcr
run
recommend
follow
c
posit
control
document
run
compar
valu
deriv
previou
run
help
identifi
loss
sensit
seen
due
user
error
degrad
pcr
reagent
c
fall
significantli
expect
valu
run
repeat
outwith
two
standard
deviat
mean
valu
determin
previou
run
test
ident
posit
control
c
remain
low
reduc
new
control
pcr
reagent
may
requir
addit
overal
fluoresc
chang
also
monitor
run
reduct
fluoresc
may
caus
interpret
difficulti
may
also
highlight
problem
pcr
reaction
chang
c
larg
reduct
fluoresc
may
result
need
repeat
pcr
introduc
new
batch
control
pcr
reagent
ideal
real
time
pcr
test
includ
intern
control
order
ensur
confid
neg
result
mani
intern
control
pcr
test
avail
target
anim
virus
ad
sampl
extract
synthet
control
ad
mastremix
human
gene
howev
inclus
control
expens
may
carri
separ
diagnost
assay
result
mani
laboratori
includ
use
control
test
laboratori
perform
real
time
pcr
assay
perform
quantit
assay
addit
suitabl
standard
quantit
control
assay
although
uniform
sampl
type
requir
obtain
meaning
result
eg
blood
urin
attempt
quantifi
viru
nonuniform
sampl
type
respiratori
sampl
stool
recommend
without
thorough
assess
sampl
reproduc
common
mani
laboratori
prepar
quantit
standard
oligo
plasmid
bulk
test
accept
linear
slope
good
dilut
seri
allow
rang
equat
variat
effici
reaction
aliquot
volum
suffici
last
week
c
aliquot
store
frozen
c
requir
essenti
track
c
valu
control
check
assay
perform
satisfactorili
enabl
smooth
transit
new
control
set
requir
fig
record
c
valu
form
shewart
control
chart
davi
newli
prepar
standard
produc
annual
must
c
valu
fall
within
two
standard
deviat
mean
valu
determin
standard
previous
use
second
issu
quantit
assay
use
extract
materi
quantit
control
assay
sensit
chang
extract
methodolog
effici
recent
move
effici
extract
kit
qiaamp
viru
robot
kit
standard
plasmid
cellular
dna
base
extract
alongsid
specimen
report
higher
viral
load
sampl
previou
extract
procedur
observ
chang
viral
load
problem
crossov
period
one
extract
procedur
anoth
subsequ
sampl
analys
light
new
baselin
level
ensur
intrarun
extract
consist
posit
intern
control
known
quantiti
extract
run
time
sampl
test
control
monitor
way
outlin
see
routin
valid
real
time
pcr
run
assay
number
assay
introduc
routin
servic
import
reassess
sensit
assay
relat
current
circul
virus
fig
applic
shewart
control
chart
track
potenti
chang
assay
perform
mean
ct
valu
obtain
copi
per
ml
standard
plot
time
averag
valu
ct
valu
calcul
plot
red
line
data
set
along
two
standard
deviat
pink
line
blue
line
averag
valu
two
standard
deviat
gener
accept
warn
level
analys
first
jump
repres
chang
set
standard
use
ideal
result
much
reproduc
assay
second
jump
b
caus
chang
primerprob
pool
use
show
signific
chang
sensit
assay
result
analysi
anoth
batch
primerprob
pool
prepar
result
obtain
return
accept
rang
interpret
refer
colour
figur
legend
reader
refer
web
version
articl
carri
use
posit
sampl
detect
altern
test
compar
primer
probe
new
sequenc
store
surveil
databas
although
assay
target
conserv
region
viral
genom
small
chang
target
result
fals
neg
reaction
due
primer
andor
probe
mismatch
loss
sensit
occur
primer
probe
sequenc
may
need
updat
new
assay
may
develop
interpret
real
time
pcr
result
rel
straightforward
process
fulli
optimis
assay
posit
result
show
increas
fluoresc
characterist
exponenti
curv
howev
still
pitfal
feel
user
made
awar
interpret
data
occasion
sampl
may
show
signal
drift
trace
increas
fluoresc
pcr
progress
exponenti
fig
signal
drift
produc
number
reason
true
posit
sampl
may
show
signal
drift
sub
optim
pcr
condit
inhibit
primer
mismatch
occasion
neg
sampl
may
also
show
signal
drift
may
due
probe
breakdown
result
fluoresc
increas
signal
drift
often
occur
toward
end
pcr
reaction
platform
allow
multicompon
analysi
weak
posit
trace
allow
user
assess
chang
fluoresc
label
reaction
genuin
posit
trace
show
exponenti
increas
fluoresc
signal
wherea
signal
drift
often
due
chang
normalis
dye
eg
rox
current
repeat
posit
sampl
ct
greater
cycl
feel
may
either
low
copi
number
posit
sampl
nonspecif
reaction
well
real
time
plate
requir
seal
optic
clear
plate
seal
pcr
take
place
occas
may
seal
properli
pcr
reagent
evapor
cycl
result
curv
may
produc
mimick
posit
pcr
reaction
correct
place
threshold
line
essenti
allow
accur
c
measur
comput
softwar
avail
current
real
time
pcr
format
automat
place
threshold
line
result
analysi
sampl
fluoresc
line
regard
posit
comput
alway
check
automat
placement
threshold
line
found
sometim
comput
place
wrongli
result
fals
posit
neg
result
fig
altern
use
fix
threshold
line
use
system
ensur
real
time
assay
directli
compar
previou
run
preclud
care
analysi
data
increas
sensit
real
time
pcr
mean
like
nest
pcr
occasion
posit
result
obtain
fig
exampl
neg
sampl
show
signal
drift
two
sampl
shown
blue
show
increas
flouresc
examin
use
quantif
option
shown
left
analysi
raw
cycl
data
shown
right
show
increas
flouresc
usual
associ
posit
sampl
keep
accept
knowledg
exampl
herp
virus
throat
swab
interpret
care
often
detect
low
posit
ebv
hsv
cmv
throat
swab
case
respiratori
infect
whether
caus
diseas
unrel
reactiv
unclear
although
find
may
irrelev
clinic
ill
import
result
ignor
gain
experi
sensit
assay
may
identifi
new
previous
unrecognis
syndrom
attribut
particular
viral
pathogen
doubt
come
year
increas
number
virolog
laboratori
utilis
real
time
fig
turn
around
time
respiratori
sampl
pcr
assay
result
virolog
laboratori
abl
offer
test
process
sampl
reduc
turn
around
time
highlight
winter
respiratori
surveil
servic
servi
current
test
pathogen
season
sampl
test
result
report
within
day
sampl
arriv
laboratori
fig
gel
base
pcr
use
detect
influenza
b
rsv
picornaviru
sampl
test
total
result
avail
day
result
return
user
within
day
slightli
extend
work
day
real
time
pcr
result
ought
report
within
h
receipt
routin
use
real
time
pcr
sever
benefit
first
aid
patient
manag
prognosi
treatment
guidanc
infect
control
may
assist
develop
new
antivir
therapi
real
time
pcr
also
improv
sensit
surveil
viral
pathogen
increas
understand
import
infect
provid
accur
assess
morbid
econom
cost
diseas
facilit
implement
public
health
prevent
measur
